These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 12606630)

  • 1. Structure-activity relations of successful pharmacologic chaperones for rescue of naturally occurring and manufactured mutants of the gonadotropin-releasing hormone receptor.
    Janovick JA; Goulet M; Bush E; Greer J; Wettlaufer DG; Conn PM
    J Pharmacol Exp Ther; 2003 May; 305(2):608-14. PubMed ID: 12606630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new gonadotrophin-releasing hormone partial agonists.
    Leaños-Miranda A; Ulloa-Aguirre A; Cervini LA; Janovick JA; Rivier J; Conn PM
    J Endocrinol; 2006 Jun; 189(3):509-17. PubMed ID: 16731782
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rescue of hypogonadotropic hypogonadism-causing and manufactured GnRH receptor mutants by a specific protein-folding template: misrouted proteins as a novel disease etiology and therapeutic target.
    Janovick JA; Maya-Nunez G; Conn PM
    J Clin Endocrinol Metab; 2002 Jul; 87(7):3255-62. PubMed ID: 12107234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutations in the human gonadotropin-releasing hormone receptor: insights into receptor biology and function.
    Bédécarrats GY; Kaiser UB
    Semin Reprod Med; 2007 Sep; 25(5):368-78. PubMed ID: 17710733
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dominant-negative action of disease-causing gonadotropin-releasing hormone receptor (GnRHR) mutants: a trait that potentially coevolved with decreased plasma membrane expression of GnRHR in humans.
    Leaños-Miranda A; Ulloa-Aguirre A; Ji TH; Janovick JA; Conn PM
    J Clin Endocrinol Metab; 2003 Jul; 88(7):3360-7. PubMed ID: 12843188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Addition of catfish gonadotropin-releasing hormone (GnRH) receptor intracellular carboxyl-terminal tail to rat GnRH receptor alters receptor expression and regulation.
    Lin X; Janovick JA; Brothers S; Blömenrohr M; Bogerd J; Conn PM
    Mol Endocrinol; 1998 Feb; 12(2):161-71. PubMed ID: 9482659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Calnexin regulated gonadotropin-releasing hormone receptor plasma membrane expression.
    Brothers SP; Janovick JA; Conn PM
    J Mol Endocrinol; 2006 Dec; 37(3):479-88. PubMed ID: 17170088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolved regulation of gonadotropin-releasing hormone receptor cell surface expression.
    Janovick JA; Ulloa-Aguirre A; Conn PM
    Endocrine; 2003 Dec; 22(3):317-27. PubMed ID: 14709805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular basis of hypogonadotropic hypogonadism: restoration of mutant (E(90)K) GnRH receptor function by a deletion at a distant site.
    Maya-Núñez G; Janovick JA; Ulloa-Aguirre A; Söderlund D; Conn PM; Méndez JP
    J Clin Endocrinol Metab; 2002 May; 87(5):2144-9. PubMed ID: 11994356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human loss-of-function gonadotropin-releasing hormone receptor mutants retain wild-type receptors in the endoplasmic reticulum: molecular basis of the dominant-negative effect.
    Brothers SP; Cornea A; Janovick JA; Conn PM
    Mol Endocrinol; 2004 Jul; 18(7):1787-97. PubMed ID: 15105440
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel 68Ga- and 18F-labeled GnRH-I analogues with high GnRHR-targeting efficiency.
    Schottelius M; Berger S; Poethko T; Schwaiger M; Wester HJ
    Bioconjug Chem; 2008 Jun; 19(6):1256-68. PubMed ID: 18510351
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Receptor-misrouting: an unexpectedly prevalent and rescuable etiology in gonadotropin-releasing hormone receptor-mediated hypogonadotropic hypogonadism.
    Leaños-Miranda A; Janovick JA; Conn PM
    J Clin Endocrinol Metab; 2002 Oct; 87(10):4825-8. PubMed ID: 12364481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parallel regulation of membrane trafficking and dominant-negative effects by misrouted gonadotropin-releasing hormone receptor mutants.
    Knollman PE; Janovick JA; Brothers SP; Conn PM
    J Biol Chem; 2005 Jul; 280(26):24506-14. PubMed ID: 15886197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overlapping, nonidentical binding sites of different classes of nonpeptide antagonists for the human gonadotropin-releasing hormone receptor.
    Betz SF; Reinhart GJ; Lio FM; Chen C; Struthers RS
    J Med Chem; 2006 Jan; 49(2):637-47. PubMed ID: 16420049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Four naturally occurring mutations in the human GnRH receptor affect ligand binding and receptor function.
    Bédécarrats GY; Linher KD; Janovick JA; Beranova M; Kada F; Seminara SB; Michael Conn P; Kaiser UB
    Mol Cell Endocrinol; 2003 Jul; 205(1-2):51-64. PubMed ID: 12890567
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chimeric GnRH-LH receptors and LH receptors lacking C-terminus palmitoylation sites do not localize to plasma membrane rafts.
    Lei Y; Hagen GM; Smith SM; Barisas BG; Roess DA
    Biochem Biophys Res Commun; 2005 Nov; 337(2):430-4. PubMed ID: 16202972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. G protein-coupled receptor trafficking in health and disease: lessons learned to prepare for therapeutic mutant rescue in vivo.
    Conn PM; Ulloa-Aguirre A; Ito J; Janovick JA
    Pharmacol Rev; 2007 Sep; 59(3):225-50. PubMed ID: 17878512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular loop 3 (EL3) and EL3-proximal transmembrane helix 7 of the mammalian type I and type II gonadotropin-releasing hormone (GnRH) receptors determine differential ligand selectivity to GnRH-I and GnRH-II.
    Li JH; Choe H; Wang AF; Maiti K; Wang C; Salam A; Chun SY; Lee WK; Kim K; Kwon HB; Seong JY
    Mol Pharmacol; 2005 Apr; 67(4):1099-110. PubMed ID: 15635044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro coexpression and pharmacological rescue of mutant gonadotropin-releasing hormone receptors causing hypogonadotropic hypogonadism in humans expressing compound heterozygous alleles.
    Leaños-Miranda A; Ulloa-Aguirre A; Janovick JA; Conn PM
    J Clin Endocrinol Metab; 2005 May; 90(5):3001-8. PubMed ID: 15728205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of the gonadotropin-releasing hormone receptor (GnRHR) by RGS proteins: role of the GnRHR carboxyl-terminus.
    Castro-Fernández C; Conn PM
    Mol Cell Endocrinol; 2002 Jun; 191(2):149-56. PubMed ID: 12062898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.